Explore 3 Stock Ideas & Industry Insights Download Free Report

Carasent ASA

Company price
None GBX 0.00(0%)
Last update at 2024-06-04T03:30:18.665264Z
Market Cap
0.00M
P/E
0.26

Momentum Score

…

Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as care givers; and Ad Curis, a journal and professional system that delivers forward-thinking services to rehabilitation, substance abuse treatment, and mental health care, as well as organizations within upbringing and preventive works. It also provides Metodika EPM, a solution for medium sized private clinics and hospitals; Medrave M4, a program that offers healthcare professionals with an overview of the patient treatment group; Confrere, a video solution for physicians; and Plustoo, a software solution that collects, analyses, and visualizes data, as well as enables occupational health providers, employers, and employees to collaborate for healthy and sustainable work environment. In addition, the company provides Ad Voca; and Ad Opus, a system that structures work processes to follow-up participants in a course of measures for companies that work with inclusion into working life. Carasent ASA was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. The company was founded in 1997 and is based in Oslo, Norway.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
10.00
Low
14.27
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
-
Dividend Yield
17.97%
Revenue TTM
235.22M
Revenue Per Share
2.95
Gross Profit TTM
161.42M
Debt / Equity
0.03
ROE
-5.54%
Net Debt
-
ROCE
-0.14%
Diluted EPS TTM
0.45

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - -35.67M 4.19M -6.79M
Net income - - -38.13M 3.21M -7.03M
Selling general administrative - - 40.73M 27.32M 22.00M
Gross profit - - 56.79M 39.18M 18.93M
Ebit -0.66M 13.60M 9.19M 4.48M -2.55M
Operating income - - 3.43M 4.48M -6.75M
Other operating expenses - 15.03M 15.03M 5.75M 2.72M
Interest expense - 0.00M 0.00M 0.00M 0.00M
Tax provision - - 2.46M 0.98M 0.24M
Interest income - - 0.69M 0.26M 0.08M
Income tax expense 2.70M 3.88M 2.46M 0.98M 0.24M
Total revenue - - 70.58M 47.93M 23.96M
Cost of revenue - - 13.79M 8.74M 5.03M
Net income applicable to common shares 31.17M -0.15M -38.13M 3.21M -7.03M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets - - 504.95M 136.66M 119.24M
Intangible assets - - 78.44M 40.58M 38.22M
Other current assets - - 0.00M -0.00M -
Total liab - - 103.97M 46.08M 27.81M
Total stockholder equity - - 400.98M 90.58M 91.43M
Deferred long term liab - 50.73M 23.01M - -
Other current liab 36.65M 24.14M 15.69M 8.24M 6.63M
Common stock 106.06M 104.72M 73.31M 54.12M 54.12M
Retained earnings -5.27M -36.44M -36.29M 1.84M 1.49M
Other liab 22.13M 9.86M 50.05M 9.79M 7.25M
Good will - - 170.34M 58.81M 61.53M
Other assets 0.00M 51.06M 24.13M - -0.00M
Cash - - 221.16M 10.93M 8.77M
Total current liabilities 93.32M 109.05M 41.16M 21.01M 18.50M
Short long term debt total - - 12.76M 15.29M 2.06M
Other stockholder equity -10.56M -2.56M 9.33M -1.21M -0.00M
Property plant equipment 40.02M 16.12M 17.11M 17.65M 0.68M
Total current assets 734.21M 909.47M 237.94M 19.62M 18.82M
Net tangible assets 629.94M 847.10M 175.21M -8.81M -8.32M
Net receivables 30.24M 23.55M 14.59M 8.13M 9.28M
Long term debt - - - 1.13M 2.06M
Accounts payable 20.25M 8.94M 4.88M 1.92M 3.34M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Change to liabilities 10.08M 2.56M 1.15M -1.32M 2.79M
Total cashflows from investing activities -196.45M -125.12M -76.12M -10.77M -24.00M
Net borrowings -7.35M -4.87M -3.54M -1.91M -0.74M
Total cash from financing activities -9.39M 756.56M 268.32M 0.57M -29.30M
Change to operating activities -13.30M 3.63M 4.56M 2.03M 5.44M
Net income 31.17M -0.15M -38.13M 3.21M -7.03M
Change in cash -186.48M 662.60M 210.23M 2.15M -52.94M
Total cash from operating activities 20.56M 32.48M 18.76M 12.34M 0.36M
Depreciation 34.08M 9.31M 6.73M 3.66M 3.69M
Other cashflows from investing activities - - -0.00M -0.00M -0.00M
Change to account receivables -3.38M -3.82M -0.83M 0.72M -4.71M
Sale purchase of stock - - 286.47M - -
Other cashflows from financing activities -7.52M -29.33M -14.61M -0.29M -0.29M
Change to netincome -38.09M 6.92M 39.38M 0.31M 0.20M
Capital expenditures 91.56M 38.23M 16.13M 10.73M 10.73M
Change in working capital - - 2.72M 0.47M 3.20M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0R15
SoftBank Group Corp.
248.00
5.84%
4494.00 - - - -
0R1E
Nintendo Co. Ltd.
-115.00
1.34%
8476.00 - - - -
0LC3
Synchrony Financial
2.34
3.20%
75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A
0.15
0.12%
122.47 0.25 - 1.18 -

Profile*

Carasent ASA

Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as care givers; and Ad Curis, a journal and professional system that delivers forward-thinking services to rehabilitation, substance abuse treatment, and mental health care, as well as organizations within upbringing and preventive works. It also provides Metodika EPM, a solution for medium sized private clinics and hospitals; Medrave M4, a program that offers healthcare professionals with an overview of the patient treatment group; Confrere, a video solution for physicians; and Plustoo, a software solution that collects, analyses, and visualizes data, as well as enables occupational health providers, employers, and employees to collaborate for healthy and sustainable work environment. In addition, the company provides Ad Voca; and Ad Opus, a system that structures work processes to follow-up participants in a course of measures for companies that work with inclusion into working life. Carasent ASA was formerly known as Apptix ASA and changed its name to Carasent ASA in May 2019. The company was founded in 1997 and is based in Oslo, Norway.

Oevre Slottsgate 2B, Oslo, Norway, 0157

164

Name Title Year Born
Mr. Niclas Hugosson Founder,Chief Product Officer & Bus. Developer NA
Mr. Daniel Ohman Chief Exec. Officer 1980
Mr. Svein Martin Bjornstad Chief Financial Officer NA
Johan Eltes Chief Technical Officer NA
Advocate Jon Schultz Legal Counsel NA
Mr. Chris Damvakaris VP of Sales & Bus. Devel. NA
Cornelia Broqvist Chief Marketing Officer NA
Kajsa Conradi Chief People Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…